Submit manuscript...
Journal of
eISSN: 2373-6453

Human Virology & Retrovirology

Opinion Volume 5 Issue 4

Human Rabies: Really 100% Fatal?

Attapon Cheepsattayakorn,1,2,3 Ruangrong Cheepsattayakorn4

1Editor-in-Chief, Journal of Human Virology and Retrovirology, USA
210th Zonal Tuberculosis and Chest Disease center, Thailand
3Department of Disease Control, Ministry of Public Health, Thailand
4Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand

Correspondence: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang, Chiang Mai 50100, Thailand, Tel 66 53 140767, 66 53 276364, Fax 66 53 140773, 66 53 273590

Received: May 31, 2017 | Published: June 2, 2017

Citation: Cheepsattayakorn A, Cheepsattayakorn R (2017) Human Rabies: Really 100% Fatal. J Hum Virol Retrovirol 5(4): 00165. DOI: 10.15406/jhvrv.2017.05.00165

Download PDF

Opinion

Rabies virus is a single-stranded, rod- or bullet-shaped, and negative-sense, unsegmented, enveloped ribonucleic acid (RNA) virus with five-protein encoding viral genome. A human rabies virus, strain H-08-1320, from Sri Lanka was complete genome sequencing which indicated that this strain formed an independent lineage and did not cluster with rabies viruses from other countries. In the past, at least 7 cases of rabies were recovered from rabies, for example, an American female case with rabies-positive neck skin. This virus is classified in family “Rhabdoviridae” that consists of more than 100 single-stranded viruses and can infect vertebrates, invertebrates, and plants. Rabies has been recognized for more than 4,000 years. Currently, rabies disease is identified in most countries except naturally unreported regions, such as Australian islands. Approximately, 60,000 human rabies deaths occur annually, whereas more than 15 million individuals receive post-exposure prophylaxis every year. Countries with hyperendemic canine rabies, such Asia, Africa, and Latin America are at the highest risk of rabies. During the 1940-50s, domestic animal rabies in the United States and Europe was largely controlled. The incubation period is 2-3 months by average after animal bites and death occurs within 2 weeks after the presentation of the clinical manifestations. Four out of every 10 deaths due to rabies are in younger children of less than 15 years old. About 40 % of children aged 5-14 years in Asia and Africa receive post-exposure prophylaxis, whereas male patients are the majority of treated cases. Nonbite exposures can occur via mucosal contact, but rarely cause human rabies. The clinical symptoms are often nonspecific. The direct immunofluorescence test is the most sensitive and specific method for detecting rabies antigen in the fresh tissue, including skin and brain. The detection of rabies virus-neutralizing antibody performed by rapid fluorescence focus inhibition test (RFFIT) in the serum of unvaccinated persons is also diagnostic. The presence of rabies virus neutralizing antibody in the cerebrospinal fluid is the confirmed diagnosis, but the antibody may appear 2-3 days later than the serum antibody. Post-exposure prophylaxis is promptly and necessary which consists of the combination of local wound cleansing, rabies vaccine, and human rabies immune globulin (HRIG). Interferon-gamma, ketamine, and ribavirin are specific therapies. Currently, human diploid cell vaccine (HDCV) and rabies vaccine adsorbed (RVA) are the two cell culture products that are licensed in the United States.

Conclusion

Mass dog and cat vaccination programs should be performed in the rabies endemic areas that successfully reduced rabies in canine and humans in the United States and Europe. Combination therapy may be superior to single agent therapy.

Acknowledgments

None.

Conflicts of interest

None.

References

  1. Depression and other common mental disorders: global health estimates. World Health Organization; 2017. 1–24 p.
  2. Benneh CK, Biney RP, Mante PK, et al. Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish-Involvement of GABAergic and 5-HT systems. Journal of Ethnopharmacology. 2017;207:129–145.
  3. Kato H, Tsuji M, Miyagawa K, et al. Repeated exposure to stress stimuli during ethanol consumption prolongs withdrawal-induced emotional abnormality in mice. European Journal of Pharmacology. 2013;721(1-3):29–34.
  4. Carmichael O, Lockhart S. The Role of Diffusion Tensor Imaging in the Study of Cognitive Aging. Curr Top Behav Neurosci. 2012;11:289–320.
  5. Hood SD, Norman A, Hince DA, et al. Benzodiazepine dependence and its treatment with low dose flumazenil. British Journal of Clinical Pharmacology. 2014;77(2):285–294.
  6. Graf H, Walter M, Metzger CD, et al. Antidepressant-related sexual dysfunction-Perspectives from neuroimaging. Pharmacology Biochemistry and Behavior. 2014;121:138–145.
  7. López-Rubalcava C, Estrada-Camarena E. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. Journal of Ethnopharmacology. 2016;186:377–391.
  8. Harro J. Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why. Behavioural Brain Research. 2018;352:81–93.
  9. Frantz S. Therapeutic area influences drug development costs. Nature reviews Drug Discovery. 2004;3(6):466–467.
  10. Panula P, Sallinen V, Sundvik M, et al. Modulatory Neurotransmitter Systems and Behavior: Towards Zebrafish Models of Neurodegenerative Diseases. Zebrafish. 2006;3(2):235–247.
  11. Venuprasad MP, Kumar Kandikattu H, Razack S, et al. Phytochemical analysis of Ocimum gratissimum by LC-ESI-MS/MS and its antioxidant and anxiolytic effects. South African Journal of Botany. 2014;92:151–158.
  12. Fernandez SP, Nguyen M, Yow TT, et al. The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice. Neurochemical Research. 2009;34(10):1867–1875.
  13. Batista FLA, Luiza MG, Araújo JIB, et al Antinociceptive activity of ethanolic extract of Azadirachta indica A. Juss (Neem, Meliaceae) fruit through opioid, glutamatergic and acid-sensitive ion pathways in adult zebrafish (Danio rerio). Biomedicine & Pharmacotherapy. 2018;108:408–416.
  14. Khosla P, Singh BSJ, Srivastava RK. Antinociceptive Activity of Azadirachta Indica Antinociceptive Activity of Azadirachta Indica (Neem ) in Rats. Indian Journal of Pharmacology. 2000;32(6):372–374.
  15. Maiti R, Kumar S, Acharya S, e al. Role of aqueous extract of Azadirachta indica leaves in an experimental model of Alzheimer′s disease in rats. International Journal of Applied and Basic Medical Research. 2013;3(1):37–47.
Creative Commons Attribution License

©2017 Cheepsattayakorn, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.

Citations